ProfileGDS4718 / 233345_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 32% 33% 37% 34% 36% 40% 34% 37% 34% 30% 24% 35% 38% 41% 35% 40% 32% 39% 36% 39% 31% 33% 34% 40% 35% 30% 35% 20% 39% 43% 42% 32% 34% 31% 40% 43% 35% 26% 31% 34% 39% 34% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5658930
GSM549102patient 115, normal, homogenized [OPG study]4.6643732
GSM549104patient 119, normal, homogenized [OPG study]4.6599333
GSM549108patient 138, normal, homogenized [OPG study]4.8863737
GSM549119patient 077, normal, homogenized [OPG study]4.7417334
GSM549133patient 032, cancer, homogenized [OPG study]4.7553536
GSM549139patient 042, cancer, homogenized [OPG study]4.9545240
GSM549099patient 107, normal, homogenized [OPG study]4.7432634
GSM549109patient 139, normal, homogenized [OPG study]4.8637937
GSM549110patient 046, normal, homogenized [OPG study]4.7177734
GSM549114patient 063, normal, homogenized [OPG study]4.4885230
GSM549122patient 082, normal, homogenized [OPG study]4.2958924
GSM549134patient 033, cancer, homogenized [OPG study]4.7663235
GSM549136patient 036, cancer, homogenized [OPG study]4.8533638
GSM549140patient 044, cancer, homogenized [OPG study]5.0074541
GSM549111patient 047, normal, homogenized [OPG study]4.7120835
GSM549113patient 057, normal, homogenized [OPG study]4.9486340
GSM549132patient 031, cancer, homogenized [OPG study]4.6230732
GSM549137patient 038, cancer, homogenized [OPG study]4.9203139
GSM549142patient 047, cancer, homogenized [OPG study]4.9182636
GSM549100patient 110, normal, homogenized [OPG study]4.9851539
GSM549107patient 135, normal, homogenized [OPG study]4.5713931
GSM549115patient 068, normal, homogenized [OPG study]4.5916533
GSM549116patient 072, normal, homogenized [OPG study]4.6677334
GSM549120patient 078, normal, homogenized [OPG study]4.9645540
GSM549131patient 030, cancer, homogenized [OPG study]4.6811735
GSM549118patient 074, normal, homogenized [OPG study]4.5510330
GSM549129patient 027, cancer, homogenized [OPG study]4.7833335
GSM549123patient 088, normal, homogenized [OPG study]4.1290520
GSM549124patient 006, cancer, homogenized [OPG study]4.9801439
GSM549126patient 015, cancer, homogenized [OPG study]5.1148143
GSM549128patient 025, cancer, homogenized [OPG study]5.0765742
GSM549103patient 117, normal, homogenized [OPG study]4.6619432
GSM549117patient 073, normal, homogenized [OPG study]4.6794934
GSM549138patient 041, cancer, homogenized [OPG study]4.570131
GSM549141patient 045, cancer, homogenized [OPG study]4.9426240
GSM549130patient 028, cancer, homogenized [OPG study]5.1480743
GSM549101patient 111, normal, homogenized [OPG study]4.7818235
GSM549105patient 128, normal, homogenized [OPG study]4.3764126
GSM549106patient 134, normal, homogenized [OPG study]4.5192931
GSM549112patient 048, normal, homogenized [OPG study]4.6830934
GSM549125patient 011, cancer, homogenized [OPG study]4.9614439
GSM549127patient 024, cancer, homogenized [OPG study]4.6884634
GSM549135patient 035, cancer, homogenized [OPG study]4.728635